India to Philippines: Erlotinib Export Trade Route
India has recorded 31 verified shipments of Erlotinib exported to Philippines, representing a combined trade value of $331.5K USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $10.7K USD. The leading Indian exporter is VEXXA LIFESCIENCES PVT. LTD. , which accounts for 47% of total export value with 11 shipments worth $156.3K USD. On the buying side, Ve Pharma Inc. is the largest importer in Philippines with $156.3K USD in purchases. The top 3 suppliers — VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PRIVATE LIMITED — together control 88% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Erlotinib corridor is one of India's established pharmaceutical export routes, with 31 shipments documented worth a combined $331.5K USD. The route is dominated by VEXXA LIFESCIENCES PVT. LTD. , which alone accounts for roughly 47% of all export value, reflecting the consolidated nature of India's erlotinib manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $10.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with erlotinib's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 14.8%, placing it at rank #19 among India's top erlotinib export destinations globally.
On the import side, key buyers of Indian erlotinib in Philippines include Ve Pharma Inc. , VE PHARMA INC, Ve Pharma Inc. and 6 others. Ve Pharma Inc. is the single largest importer with 11 shipments valued at $156.3K USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ2
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#19
- Annual growth+14.8%
- Demand growth+12.9%
- Regulatory ease90/100
Top 10 Indian Erlotinib Exporters to Philippines
Showing top 10 of 7 Indian suppliers exporting Erlotinib to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VEXXA LIFESCIENCES PVT. LTD. Avg $14.2K per shipment | 11 | $156.3K | 47.2% |
| 2 | VEXXA LIFESCIENCES PVT. LTD. Avg $19.4K per shipment | 5 | $97.1K | 29.3% |
| 3 | VEXXA LIFESCIENCES PRIVATE LIMITED Avg $12.5K per shipment | 3 | $37.4K | 11.3% |
| 4 | VEXXA LIFESCIENCES PVT LTD Avg $18.3K per shipment | 2 | $36.6K | 11.1% |
| 5 | SANSKRUTI PHARMA Avg $475 per shipment | 8 | $3.8K | 1.1% |
| 6 | YARAPMIN LIFECARE Avg $160 per shipment | 1 | $160 | 0.0% |
| 7 | ODDWAY INTERNATIONAL Avg $110 per shipment | 1 | $110 | 0.0% |
This table shows the top 10 of 7 Indian companies exporting erlotinib to Philippines, ranked by total trade value. The listed exporters are: VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PRIVATE LIMITED, VEXXA LIFESCIENCES PVT LTD, SANSKRUTI PHARMA, YARAPMIN LIFECARE , ODDWAY INTERNATIONAL. VEXXA LIFESCIENCES PVT. LTD. is the dominant supplier with 11 shipments worth $156.3K USD, giving it a 47% market share. The top 3 suppliers together account for 88% of the total trade value on this route.
Top 10 Erlotinib Importers in Philippines
Showing top 10 of 9 known buyers in Philippines receiving Erlotinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian erlotinib in Philippines include Ve Pharma Inc. , VE PHARMA INC, Ve Pharma Inc., VE PHARMA INC., CLIENT CODE PH001, among 9 total buyers. The largest importer is Ve Pharma Inc. , accounting for $156.3K USD across 11 shipments — representing 47% of all erlotinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Ve Pharma Inc. | 11 | $156.3K | 47.2% |
| 2 | VE PHARMA INC | 8 | $142.3K | 42.9% |
| 3 | Ve Pharma Inc. | 1 | $19.3K | 5.8% |
| 4 | VE PHARMA INC. | 1 | $9.5K | 2.9% |
| 5 | CLIENT CODE PH001 | 6 | $3.0K | 0.9% |
| 6 | CLIENT CODE | 1 | $449 | 0.1% |
| 7 | CLIENT CODE PH001, | 1 | $310 | 0.1% |
| 8 | CUSTOMER NUMBER: YL-0090 | 1 | $160 | 0.0% |
| 9 | CYNTHIA R SANCHEZ | 1 | $110 | 0.0% |
Top 10 Erlotinib Formulations Imported by Philippines
Showing top 10 of 21 product formulations shipped on the India to Philippines Erlotinib route, ranked by trade value
Philippines imports a wide range of erlotinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Ervex 150 (ERLOTINIB TABLETS 150 MG) B — accounts for $76.9K USD across 6 shipments. There are 21 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Ervex 150 (ERLOTINIB TABLETS 150 MG) B | 6 | $76.9K | 23.2% |
| 2 | Ervex 150 Tab (ERLOTINIB TABLETS 150 MG)BATCH NO-ERTB25B01-A MFG DT-FEB-2025 EXP DT-JAN-2027 | 1 | $41.6K | 12.5% |
| 3 | Ervex 150 (ERLOTINIB TABLETS 150 MG) | 2 | $38.7K | 11.7% |
| 4 | Ervex 150 ERLOTINIB TABLETS 150 MG BCH NO-ERTG23B09-A MANUFACTURING DT-JUL-2023 EXP DT-JUN-2025 | 2 | $36.6K | 11.1% |
| 5 | ERVEX 150 TAB (ERLOTINIB TABLETS 150 MG) | 1 | $21.3K | 6.4% |
| 6 | Ervex 150 (ERLOTINIB TABLETS 150 MG) BAT | 2 | $19.4K | 5.8% |
| 7 | Ervex 150 (ERLOTINIB TABLETS 150 MG) BAT | 1 | $19.3K | 5.8% |
| 8 | ERVEX 150 ERLOTINIB TABLETS 150 MG B.NO.ERTJ23B11-A MANUFACTURING DT OCT-2023 EXP DTSEP-2025 | 1 | $18.0K | 5.4% |
| 9 | ERVEX 150 TAB (ERLOTINIB TABLETS 150 MG)BCH NO-ERTL23B12-A MFG DT-DEC-2023 EXPDT-NOV-2025NOS | 1 | $17.9K | 5.4% |
| 10 | ERVEX 150 ERLOTINIB TABLETS 150 MG BATCH NO ERTH23B10-A MANUFACTURING DT AUG-2023 EXP DTJUL-2025 | 1 | $9.8K | 3.0% |
Showing top 10 of 21 Erlotinib formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 85%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 14 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's erlotinib exports to Philippines are driven primarily by a handful of large-scale manufacturers. VEXXA LIFESCIENCES PVT. LTD. with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PRIVATE LIMITED — together account for 88% of total trade value on this route. The average shipment value of $10.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as ervex 150 tab (erlotinib tablets 150 mg)batch no-ertb25b01-a mfg dt-feb-2025 exp dt-jan-2027 and ervex 150 (erlotinib tablets 150 mg) , suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, Ve Pharma Inc. is the largest importer with 11 shipments worth $156.3K USD — representing 47% of all erlotinib imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $331.5K
- Avg. Shipment
- $10.7K
- Suppliers
- 7
- Buyers
- 9
- Transit (Sea)
- ~29 days
- Annual Growth
- +14.8%
Other Erlotinib Routes
Unlock the Full India to Philippines Erlotinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 31 shipments on this route.
Frequently Asked Questions — India to Philippines Erlotinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Erlotinib to Philippines?
The leading Indian exporters of Erlotinib to Philippines are VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PRIVATE LIMITED. VEXXA LIFESCIENCES PVT. LTD. holds the largest market share at approximately 47% of total trade value on this route.
Q What is the total value of Erlotinib exports from India to Philippines?
India exports Erlotinib to Philippines worth approximately $331.5K USD across 31 recorded shipments. The average value per shipment is $10.7K USD.
Q Which ports does India use to ship Erlotinib to Philippines?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 14 shipments. Indian exporters primarily use sea freight for this route, with 85% of shipments going by sea and 30% by air.
Q How long does shipping take from India to Philippines for Erlotinib?
The average transit time for Erlotinib shipments from India to Philippines is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Philippines Erlotinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 14.8% with demand growth tracking at 12.9%. The route is ranked #19 among India's top Erlotinib export destinations globally.
Q How many suppliers are active on the India to Philippines Erlotinib route?
There are currently 7 active Indian suppliers exporting Erlotinib to Philippines. The market is moderately concentrated with VEXXA LIFESCIENCES PVT. LTD. accounting for 47% of total shipment value.
Q Who are the main importers of Erlotinib from India in Philippines?
The leading importers of Indian Erlotinib in Philippines include Ve Pharma Inc. , VE PHARMA INC, Ve Pharma Inc., VE PHARMA INC., CLIENT CODE PH001. Ve Pharma Inc. is the largest buyer with 11 shipments worth $156.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Erlotinib.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 9 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 31 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
31 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists